In a phase II randomized multicenter study, Tumlin et al. evaluated the effect on mortality of adding extracorporeal tubule cell therapy to continuous renal replacement therapy (CRRT) for patients ...

[31] Cell hypertrophy of the distal convoluted tubule results in augmented sodium reabsorption and subsequent diminished natriuretic response.